Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on December 30, 2008
JNCI Journal of the National Cancer Institute 2009 101(1):67; doi:10.1093/jnci/djn406
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
101/1/67    most recent
djn406v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Bregni, M.
Right arrow Articles by Pedrazzoli, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bregni, M.
Right arrow Articles by Pedrazzoli, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press.

CORRESPONDENCE

Re: 'A Threefold Dose Intensity Treatment With Ifosfamide, Carboplatin, and Etoposide for Patients With Small-Cell Lung Cancer: A Randomized Trial'

Marco Bregni, Paolo Pedrazzoli

Affiliations of authors: European Blood and Marrow Transplantation (EBMT) Solid Tumor Working Party (MB); Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO), Sezione Tumori Solidi (PP), Milan, Italy

Correspondence to: Paolo Pedrazzoli, MD, Gruppo Italiano per il Trapianto di Midollo Osseo, Oncologia Medica Falck, Ospedale Niguarda Ca’ Granda, 20162 Milano, Italy (e-mail: paolo.pedrazzoli@ospedaleniguarda.it).

The first 10% of the full text of this article appears below.

Leyvraz et al. (1) have recently reported on a multicenter phase 3 study of conventional dose ifosfamide, carboplatin, etoposide (ICE) vs high-dose chemotherapy (HDC) with stem cell support in patients with limited . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?